[Thiazide diuretic-induced subacute cutaneous lupus erythematosus].
Wollenberg
A
A
Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München.
Meurer
M
M
D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D003176:Complement C3 / Q000032:analysis; D004338:Drug Combinations; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects* / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007075:Immunoglobulin M / Q000032:analysis; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000473:pathology; D012867:Skin / Q000473:pathology; D014223:Triamterene / Q000009:adverse effects* / Q000627:therapeutic use
D000974:Antibodies, Antinuclear; D003176:Complement C3; D004338:Drug Combinations; D007075:Immunoglobulin M; D006852:Hydrochlorothiazide; D014223:Triamterene
Thiazid-Diuretika-induzierter subakut-kutaner Lupus erythematodes.